KC
FPRX

Kellner Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Kellner Capital’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-226,876
Closed -$8.55M – 41
2021
Q1 		$8.55M Buy
+226,876
New +$8.55M 3.1% 13